ANTIBIOTIC  BACITRACIN ZINC- bacitracin zinc ointment 
McKesson

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

antibiotic
Bacitracin Zinc

Drug Facts

Active ingredient (each gram contains)

Bacitracin Zinc 500 units

Purpose

First aid antibiotic

Uses

first aid to help prevent infection in

Warnings

For external use only

Do not use

  • in the eyes
  • over large areas of the body
  • if you are allergic to any of the ingredients
  • longer than 1 week unless directed by a doctor

Ask a doctor before use

  • on deep or puncture wounds, animal bites, or serious burns

Stop use and ask a doctor if

  • condition persists or gets worse
  • a rash or other allergic reaction develops

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

mineral oil, white petrolatum

Questions?

Call 1-866-923-4914

Distributed by McKesson
One Post Street
San Francisco, CA 94104

PRINCIPAL DISPLAY PANEL - 28.4 g Tube Carton

sunmark®

antibiotic ointment

Bacitracin Zinc Ointment USP
FIRST AID ANTIBIOTIC

NET WT 1 OZ (28.4 g)

Principal Display Panel - 28.4 g Tube Carton
ANTIBIOTIC   BACITRACIN ZINC
bacitracin zinc ointment
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:49348-154
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Bacitracin Zinc (UNII: 89Y4M234ES) (Bacitracin - UNII:58H6RWO52I) Bacitracin 500 [iU]  in 1 g
Inactive Ingredients
Ingredient Name Strength
mineral oil (UNII: T5L8T28FGP)  
petrolatum (UNII: 4T6H12BN9U)  
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49348-154-72 1 in 1 CARTON
1 28.4 g in 1 TUBE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC MONOGRAPH FINAL part333B 05/11/2006
Labeler - McKesson (177667227)
Registrant - Taro Pharmaceuticals U.S.A., Inc. (145186370)
Establishment
Name Address ID/FEI Business Operations
Taro Pharmaceuticals Inc. 206263295 MANUFACTURE(49348-154)

Revised: 2/2013
Document Id: 75e3ef84-b7c8-440c-ac49-42bd8f7d5ca2
Set id: 73cbb154-d543-4b63-ad72-5b580123d5d6
Version: 1
Effective Time: 20130201
 
McKesson